Agenus to participate in oppenheimer 34th annual healthcare life sciences conference

Lexington, mass.--(business wire)--agenus inc. (“agenus”) (nasdaq: agen), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that dr. garo armen, chairman and ceo, will participate in a fireside chat and investor one-on-ones at the upcoming oppenheimer healthcare conference on february 13th - 14th. the fireside chat will take place at 8:00 a.m. et on february 14th. a live webcast and replay of the fireside chat will be accessible on the c.
AGEN Ratings Summary
AGEN Quant Ranking